(Q44622481)

reason for preferred rank

4 December 2017

Accelerated metabolite identification by “Extraction-NMR” (English)

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

22 March 2024

Accelerated metabolite identification by "extraction-NMR" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565558

metabolite identification

22 March 2024

main subject

1 reference

inferred from title

object named as

metabolite identification

4 February 2023

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

22 March 2024

author name string

Ute Gerhard

1

1 reference

4 December 2017

Steven Thomas

2

1 reference

4 December 2017

Russell Mortishire-Smith

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14565558

22 March 2024

publication date

1 July 2003

1 reference

4 December 2017

14 July 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14565558

full work available at URL

22 March 2024

https://api.elsevier.com/content/article/PII:S0731708503002188?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

https://api.elsevier.com/content/article/PII:S0731708503002188?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

Journal of Pharmaceutical and Biomedical Analysis

22 March 2024

published in

1 reference

4 December 2017

32

1 reference

4 December 2017

531-538

1 reference

4 December 2017

3

1 reference

Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Early ADME in support of drug discovery: the role of metabolic stability studies

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

High-throughput screening approaches for investigating drug metabolism and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Directly coupled HPLC-NMR and its application to drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Directly Coupled 800 MHz HPLC−NMR Spectroscopy of Urine and Its Application to the Identification of the Major Phase II Metabolites of Tolfenamic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

750 MHz HPLC-NMR spectroscopic identification of rat microsomal metabolites of phenoxypyridines

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Directly coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

A rapid method for the isolation and identification of drug metabolites from human urine using solid phase extraction and proton NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

A comparison of quantitative NMR and radiolabelling studies of the metabolism and excretion of Statil (3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid) in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Partial purification of cytochromes P-450 and P-448 from rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

A study of flucloxacillin metabolites in rat urine by two-dimensional 1H, 19F COSY NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900218-8

7 January 2021

Drug Metabolism and Disposition

7

27

1319

Mutlib

1999

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

Drug Metabolism and Disposition

22 March 2024

15

14

746

Tulip

1986

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

Protein measurement with the Folin phenol reagent

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0731-7085(03)00218-8

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference